Viruses vs. infections: new hope for implant troubles?
NCT ID NCT07533292
First seen Apr 24, 2026 · Last updated Jun 23, 2026 · Updated 13 times
Summary
This study tests whether specially designed viruses, called bacteriophages, can eliminate persistent infections around orthopedic implants like hip or knee replacements. One hundred adults with such infections will receive the virus solution directly into the infected area after standard surgical cleaning. The main goal is to see if the bacteria are completely cleared, with a close watch on safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORTHOPEDIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
the Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China 310000, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bacteriophage preparation (viruses that kill specific bacteria)
What this could lead to
If it works, this could offer a new way to treat hard-to-cure infections around joint replacements without relying on antibiotics.
What could go wrong
This is a single-center, early-phase trial with only 100 participants, so results may not apply broadly. The therapy may not clear the infection, and allergic reactions are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.